Rimeporide

DB12861InvestigationalSmall molecule

Rimeporide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne.

Mechanism: Pharmacologically active on Sodium/hydrogen exchanger 1
Curator reviewed
Formula / weight: C₁₁H₁₅N₃O₅S₂ · 333.38 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyGROMEQPXDKRRIE-UHFFFAOYSA-NSMILESCC1=CC(=C(C=C1C(=O)NC(N)=N)S(C)(=O)=O)S(C)(=O)=O

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Rimeporide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.